Performance of the SeptiCyte LAB Test for Antibiotic Stewardship in Mesenteric Ischemia
NCT06507423 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15
Last updated 2025-04-02
Summary
This study will help determine whether the SeptiCyte LAB test can accurately differentiate between SIRS and actual infections in postoperative patients, potentially reducing unnecessary antibiotic use and improving patient outcomes in cases of acute mesenteric ischemia
Conditions
- Acute Mesenteric Ischemia
- Sepsis Bacterial
- Intra-abdominal Infection
- Digestive Inflammation
Interventions
- DEVICE
-
Septicyte Lab Test pre operative
SeptiCyte® technology uses proprietary biomarker signatures to assess the response of a patient's immune system to infections. It provides a score which can be used to differentiate sepsis from systemic inflammatory response. Each included patient will received the Septicyte LAB test before and after surgery for acute mesenteric ischemia suspicion. The results will be compared to standard of care, retrospectively.
- DEVICE
-
Septicyte Lab Test post operative
SeptiCyte® technology uses proprietary biomarker signatures to assess the response of a patient's immune system to infections. It provides a score which can be used to differentiate sepsis from systemic inflammatory response. Each included patient will received the Septicyte LAB test before and after surgery for acute mesenteric ischemia suspicion. The results will be compared to standard of care, retrospectively.
Sponsors & Collaborators
-
Central Hospital, Nancy, France
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-08-01
- Primary Completion
- 2024-09-01
- Completion
- 2024-11-01
- FDA Device
- Yes
Countries
- France
Study Locations
More Related Trials
-
EXTENDed Antibiotic Durations Compared to Standard Durations for Patients With Complicated Intra-abdominal Infection.
NCT05148702 ·Status: RECRUITING ·Phase: PHASE3
-
Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI)
NCT00230971 ·Status: COMPLETED ·Phase: PHASE4
-
Acute Intestinal Failure in Critically Ill Patients and Microbial Translocation
NCT03861325 ·Status: COMPLETED
-
Antibiotic Resistant Bacteria Among Patients With Severe Intraabdominal Infections
NCT00860587 ·Status: UNKNOWN
-
Surgical Site Infections and the Microbiome: Understanding the Pathogenesis of Surgical Site Infections
NCT06300892 ·Status: RECRUITING
-
Study of the Aortic and Large Arterial Vessel Infections
NCT05660733 ·Status: RECRUITING
-
Safety and Efficacy Study to Compare IV CXA 101/Tazobactam and Metronidazole With Meropenem in Complicated Intraabdominal Infections
NCT01147640 ·Status: COMPLETED ·Phase: PHASE2
-
Bacteria and Intestinal Translocation in Surgery (Bandit)
NCT03554148 ·Status: ACTIVE_NOT_RECRUITING
-
Procalcitonin as a Marker for the Length of Antibiotic Treatment in Peritonitis and Intra-abdominal Infections
NCT01155739 ·Status: COMPLETED
-
Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Meropenem in Complicated Intraabdominal Infections
NCT01445678 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Intestinal Microbiota
NCT07058961 ·Status: RECRUITING
-
INtestinal Dysbiosis and TRanslocation of Bacteria in Patients Undergoing Surgery
NCT05775341 ·Status: ACTIVE_NOT_RECRUITING
-
Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to ESBL- or Carbapenemase-producing Enterobacterales in Solid Organ Transplantation: an Observational Multinational Study.
NCT02852902 ·Status: COMPLETED
-
Innate Immune Response Monitoring Via Monocyte HLA-DR in Severe Intra-abdominal Infections at Risk of Fungal Infection
NCT07130799 ·Status: RECRUITING
-
Identification of Gut Microbiome Biomarkers Associated to Acquisition of Enterobacteriae Highly Resistant to Third Generation Cephalosporines Following Ceftriaxone Treatment.
NCT03569917 ·Status: TERMINATED ·Phase: NA
-
Clinical Metagenomic of Post-traumatic Infections
NCT05770856 ·Status: COMPLETED
-
Prospective Study of Drug Resistant Pathogens Among Liver, Intestinal and Multivisceral Transplant Recipients
NCT00235664 ·Status: COMPLETED
-
Fecal Microbiota Transplantation for the Prevention of Infectious Complications After Liver Transplantation
NCT06782880 ·Status: RECRUITING ·Phase: NA
-
SIS Multicenter Study of Duration of Antibiotics for Intraabdominal Infection
NCT00657566 ·Status: COMPLETED ·Phase: PHASE3
-
Prophylactic Antibiotic in Non-complicated Low Risk Lap Cholecystectomy (LC)
NCT06193837 ·Status: NOT_YET_RECRUITING
-
Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection
NCT00195351 ·Status: COMPLETED ·Phase: PHASE4
-
Multicentre Observational Study on Community Acquired Intraabdominal Infections Management
NCT03544203 ·Status: COMPLETED
-
The Preventive Infection Role of One Week Antibiotics Before Minimally Invasive Upper Tract Lithotomy
NCT02789579 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
CABI: Antibiotic Duration for Complicated Intra-ABdominal Infection
NCT03265834 ·Status: COMPLETED ·Phase: PHASE2
-
Outcomes of Empiric Antibiotic Therapy Based on Hospital Antibiograms in Organ Transplant Recipients with Bacteraemia
NCT06874920 ·Status: ENROLLING_BY_INVITATION